3Dnamics

3Dnamics is a private biotechnology company developing human stem cell-derived 3D organoid models for biomedical research, drug discovery, and translational neuroscience. Founded by stem cell and neuroscience researchers from Johns Hopkins University, the company focuses on building disease-relevant in vitro models of neurological and other human tissues using pluripotent stem cells. Its platform includes brain, liver, and heart organoids and bioreactor-based culture systems designed to improve organoid growth, survival, and reproducibility. 3Dnamics appears to operate primarily as a platform and research-tools company, while also using these systems to support preclinical therapeutic discovery for neurological diseases such as Alzheimer's disease, Parkinson's disease, ALS, and frontotemporal dementia.